Katarina Lundh will start in the position on 11.8.2025. She succeeds Atte Kukkonen, who will continue working with Galena Pharma as a member of board.
We’re excited to announce that Galena Pharma will be attending several networking and partnering events across Europe during the second half of 2025. This is a great opportunity to connect with our team in person, explore potential collaborations, and learn more about our innovative medical devices. Join us at the following events: PharmaSynergy OTC on September 24-25 in Rome, to the event page click here CPHI on October 28-30 in Frankfurt, to the event page click here euroPLX by RauCon on November 24-25 in Berlin, to the event page click here About Galena Pharma Galena Pharma is a GMP- and MDR-certified pharmaceutical company specializing in the development and manufacturing of substance-based medical devices. We offer ready-to-market, MDR-approved medical devices available for in-licensing as a private label product. Our key focus areas include Gastrointestinal health, Female intimate care, Cough & cold, Pain relief and Skin care. Let’s meet and discuss how we can success together! More information and meeting appointments: Hrvoje Pervan, Sales Director, Central Europe hrvoje.pervan (at) galena.fi
During the spring of 2025, operations of Galena Pharma were re-certified to comply with the ISO 14001 environmental management system. As a result of the certification audit, we are pleased to announce that our operations consider environmental aspects with an excellent manner, and our renewed ISO 14001 certificate is now valid until 2028.
